Glazer Capital, LLC Chimerix Inc Put Options Transaction History
Glazer Capital, LLC
- $2.98 Billion
- Q3 2025
Put Options
1 transactions
Others Institutions Holding CMRX
# of Institutions
10Shares Held
1.89MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY907KShares$7.74 Million0.0% of portfolio
-
Cibra Capital LTD London, X0732KShares$6.25 Million2.13% of portfolio
-
Credit Suisse Ag Zurich, V894KShares$802,7590.0% of portfolio
-
Dowling & Yahnke LLC San Diego, CA64.1KShares$547,0290.06% of portfolio
-
Ajo Vista, LLC Boston, MA38.3KShares$327,3290.15% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $748M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...